Listed

Grace Therapeutics, Inc.

GRCENasdaqCIK 1444192HealthcareFiscal year ends Mar 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$15.9m, Q1 FY2027
Net income−$15.8m, Q1 FY2027
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m0.5Research and development, Q2 FY2024, three months to 2023-09-30$460.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure1.4Research and development, Q3 FY2024, three months to 2023-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure1.7Research and development, Q4 FY2024, three months to 2024-03-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-06-23, accession 0001140361-25-023259. Derived: 12-month figure less the 9-month figure.Report this figure2.7Research and development, Q1 FY2025, three months to 2024-06-30$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure3.0Research and development, Q2 FY2025, three months to 2024-09-30$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure2.2Research and development, Q3 FY2025, three months to 2024-12-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure1.6Research and development, Q4 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure1.0Research and development, Q1 FY2026, three months to 2025-06-30$955.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure0.6Research and development, Q2 FY2026, three months to 2025-09-30$568.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure0.5Research and development, Q3 FY2026, three months to 2025-12-31$462.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure0.4Research and development, Q4 FY2026, three months to 2026-03-31$420.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure0.7Research and development, Q1 FY2027, three months to 2026-06-30$697.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Operating income$m(2.1)Operating income, Q2 FY2024, three months to 2023-09-30−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure(3.0)Operating income, Q3 FY2024, three months to 2023-12-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure(3.3)Operating income, Q4 FY2024, three months to 2024-03-31−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-06-23, accession 0001140361-25-023259. Derived: 12-month figure less the 9-month figure.Report this figure(5.0)Operating income, Q1 FY2025, three months to 2024-06-30−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure(4.8)Operating income, Q2 FY2025, three months to 2024-09-30−$4.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure(3.7)Operating income, Q3 FY2025, three months to 2024-12-31−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure(3.2)Operating income, Q4 FY2025, three months to 2025-03-31−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure(3.1)Operating income, Q1 FY2026, three months to 2025-06-30−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure(2.5)Operating income, Q2 FY2026, three months to 2025-09-30−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure(2.4)Operating income, Q3 FY2026, three months to 2025-12-31−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure(3.0)Operating income, Q4 FY2026, three months to 2026-03-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure(15.9)Operating income, Q1 FY2027, three months to 2026-06-30−$15.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Income tax$m(0.4)Income tax, Q2 FY2024, three months to 2023-09-30−$446.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure(0.2)Income tax, Q3 FY2024, three months to 2023-12-31−$208.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure(0.9)Income tax, Q4 FY2024, three months to 2024-03-31−$889.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-06-23, accession 0001140361-25-023259. Derived: 12-month figure less the 9-month figure.Report this figure(0.7)Income tax, Q1 FY2025, three months to 2024-06-30−$724.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure(0.9)Income tax, Q2 FY2025, three months to 2024-09-30−$852.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure(0.6)Income tax, Q3 FY2025, three months to 2024-12-31−$605.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure(1.0)Income tax, Q4 FY2025, three months to 2025-03-31−$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure0.0Income tax, Q2 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure0.0Income tax, Q3 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure(1.7)Income tax, Q4 FY2026, three months to 2026-03-31−$1.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2027, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Net income$m(3.3)Net income, Q2 FY2024, three months to 2023-09-30−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure(2.4)Net income, Q3 FY2024, three months to 2023-12-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure(3.2)Net income, Q4 FY2024, three months to 2024-03-31−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-06-23, accession 0001140361-25-023259. Derived: 12-month figure less the 9-month figure.Report this figure(2.6)Net income, Q1 FY2025, three months to 2024-06-30−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure(3.4)Net income, Q2 FY2025, three months to 2024-09-30−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure(4.2)Net income, Q3 FY2025, three months to 2024-12-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure0.6Net income, Q4 FY2025, three months to 2025-03-31$636.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure(3.4)Net income, Q1 FY2026, three months to 2025-06-30−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure(0.9)Net income, Q2 FY2026, three months to 2025-09-30−$938.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure(2.3)Net income, Q3 FY2026, three months to 2025-12-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure(1.2)Net income, Q4 FY2026, three months to 2026-03-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure(15.8)Net income, Q1 FY2027, three months to 2026-06-30−$15.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Diluted EPS$ per share(0.43)Diluted EPS, Q2 FY2024, three months to 2023-09-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure(0.21)Diluted EPS, Q3 FY2024, three months to 2023-12-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figurenot reported(0.24)Diluted EPS, Q1 FY2025, three months to 2024-06-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure(0.30)Diluted EPS, Q2 FY2025, three months to 2024-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure(0.36)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure(0.06)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure(0.14)Diluted EPS, Q3 FY2026, three months to 2025-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figurenot reported(0.91)Diluted EPS, Q1 FY2027, three months to 2026-06-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Basic EPS$ per share(0.43)Basic EPS, Q2 FY2024, three months to 2023-09-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure(0.21)Basic EPS, Q3 FY2024, three months to 2023-12-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figurenot reported(0.24)Basic EPS, Q1 FY2025, three months to 2024-06-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure(0.30)Basic EPS, Q2 FY2025, three months to 2024-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure(0.36)Basic EPS, Q3 FY2025, three months to 2024-12-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figurenot reported(0.21)Basic EPS, Q1 FY2026, three months to 2025-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure(0.06)Basic EPS, Q2 FY2026, three months to 2025-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure(0.14)Basic EPS, Q3 FY2026, three months to 2025-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figurenot reported(0.91)Basic EPS, Q1 FY2027, three months to 2026-06-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure

Balance sheet

Cash and equivalents$13.8m, Q1 FY2027
Shareholders' equity$48.2m, Q1 FY2027
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31FY20262026-03-31Q1 FY20272026-06-30
Cash and equivalents$m27.0Cash and equivalents, Q2 FY2024, at 2023-09-30$27.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0000950170-23-062437.Report this figure18.5Cash and equivalents, Q3 FY2024, at 2023-12-31$18.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-12, accession 0000950170-24-013566.Report this figure23.0Cash and equivalents, FY2024, at 2024-03-31$23.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-06-23, accession 0001140361-25-023259.Report this figure19.4Cash and equivalents, Q1 FY2025, at 2024-06-30$19.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0000950170-24-094348.Report this figure15.2Cash and equivalents, Q2 FY2025, at 2024-09-30$15.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure11.1Cash and equivalents, Q3 FY2025, at 2024-12-31$11.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure22.1Cash and equivalents, FY2025, at 2025-03-31$22.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-06-18, accession 0001140361-26-025662.Report this figure20.0Cash and equivalents, Q1 FY2026, at 2025-06-30$20.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure16.9Cash and equivalents, Q2 FY2026, at 2025-09-30$16.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure18.7Cash and equivalents, Q3 FY2026, at 2025-12-31$18.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure17.0Cash and equivalents, FY2026, at 2026-03-31$17.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure13.8Cash and equivalents, Q1 FY2027, at 2026-06-30$13.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Current assets$m28.9Current assets, Q2 FY2024, at 2023-09-30$28.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062437.Report this figure26.9Current assets, Q3 FY2024, at 2023-12-31$26.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-12, accession 0000950170-24-013566.Report this figure24.0Current assets, FY2024, at 2024-03-31$24.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-06-23, accession 0001140361-25-023259.Report this figure20.4Current assets, Q1 FY2025, at 2024-06-30$20.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094348.Report this figure16.1Current assets, Q2 FY2025, at 2024-09-30$16.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure11.9Current assets, Q3 FY2025, at 2024-12-31$11.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure22.7Current assets, FY2025, at 2025-03-31$22.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-06-18, accession 0001140361-26-025662.Report this figure20.5Current assets, Q1 FY2026, at 2025-06-30$20.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure17.3Current assets, Q2 FY2026, at 2025-09-30$17.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure19.2Current assets, Q3 FY2026, at 2025-12-31$19.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure17.4Current assets, FY2026, at 2026-03-31$17.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure14.3Current assets, Q1 FY2027, at 2026-06-30$14.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Total assets$m78.2Total assets, Q2 FY2024, at 2023-09-30$78.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0000950170-23-062437.Report this figure76.2Total assets, Q3 FY2024, at 2023-12-31$76.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-12, accession 0000950170-24-013566.Report this figure73.3Total assets, FY2024, at 2024-03-31$73.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-06-23, accession 0001140361-25-023259.Report this figure69.7Total assets, Q1 FY2025, at 2024-06-30$69.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0000950170-24-094348.Report this figure65.3Total assets, Q2 FY2025, at 2024-09-30$65.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure61.2Total assets, Q3 FY2025, at 2024-12-31$61.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure72.0Total assets, FY2025, at 2025-03-31$72.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-06-18, accession 0001140361-26-025662.Report this figure69.8Total assets, Q1 FY2026, at 2025-06-30$69.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure66.6Total assets, Q2 FY2026, at 2025-09-30$66.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure68.5Total assets, Q3 FY2026, at 2025-12-31$68.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure66.7Total assets, FY2026, at 2026-03-31$66.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure50.1Total assets, Q1 FY2027, at 2026-06-30$50.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Current liabilities$m1.4Current liabilities, Q2 FY2024, at 2023-09-30$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062437.Report this figure1.8Current liabilities, Q3 FY2024, at 2023-12-31$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-12, accession 0000950170-24-013566.Report this figure1.7Current liabilities, FY2024, at 2024-03-31$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-06-23, accession 0001140361-25-023259.Report this figure2.6Current liabilities, Q1 FY2025, at 2024-06-30$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094348.Report this figure2.7Current liabilities, Q2 FY2025, at 2024-09-30$2.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure2.0Current liabilities, Q3 FY2025, at 2024-12-31$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure1.9Current liabilities, FY2025, at 2025-03-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-06-18, accession 0001140361-26-025662.Report this figure2.3Current liabilities, Q1 FY2026, at 2025-06-30$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure1.2Current liabilities, Q2 FY2026, at 2025-09-30$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure1.3Current liabilities, Q3 FY2026, at 2025-12-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure2.1Current liabilities, FY2026, at 2026-03-31$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure1.3Current liabilities, Q1 FY2027, at 2026-06-30$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Total liabilities$m11.5Total liabilities, Q2 FY2024, at 2023-09-30$11.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0000950170-23-062437.Report this figure11.5Total liabilities, Q3 FY2024, at 2023-12-31$11.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-12, accession 0000950170-24-013566.Report this figure11.6Total liabilities, FY2024, at 2024-03-31$11.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-06-23, accession 0001140361-25-023259.Report this figure10.4Total liabilities, Q1 FY2025, at 2024-06-30$10.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0000950170-24-094348.Report this figure9.2Total liabilities, Q2 FY2025, at 2024-09-30$9.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure9.1Total liabilities, Q3 FY2025, at 2024-12-31$9.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure5.4Total liabilities, FY2025, at 2025-03-31$5.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-06-18, accession 0001140361-26-025662.Report this figure6.3Total liabilities, Q1 FY2026, at 2025-06-30$6.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure3.8Total liabilities, Q2 FY2026, at 2025-09-30$3.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure3.6Total liabilities, Q3 FY2026, at 2025-12-31$3.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure2.8Total liabilities, FY2026, at 2026-03-31$2.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure1.9Total liabilities, Q1 FY2027, at 2026-06-30$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Shareholders' equity$m66.7Shareholders' equity, Q2 FY2024, at 2023-09-30$66.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure64.7Shareholders' equity, Q3 FY2024, at 2023-12-31$64.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure61.7Shareholders' equity, FY2024, at 2024-03-31$61.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-06-18, accession 0001140361-26-025662.Report this figure59.4Shareholders' equity, Q1 FY2025, at 2024-06-30$59.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure56.1Shareholders' equity, Q2 FY2025, at 2024-09-30$56.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure52.1Shareholders' equity, Q3 FY2025, at 2024-12-31$52.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure66.6Shareholders' equity, FY2025, at 2025-03-31$66.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure63.6Shareholders' equity, Q1 FY2026, at 2025-06-30$63.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure62.8Shareholders' equity, Q2 FY2026, at 2025-09-30$62.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure64.9Shareholders' equity, Q3 FY2026, at 2025-12-31$64.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure63.9Shareholders' equity, FY2026, at 2026-03-31$63.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure48.2Shareholders' equity, Q1 FY2027, at 2026-06-30$48.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure

Cash flow

Operating cash flow−$3.2m, Q1 FY2027
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Operating cash flow$k(2,113)Operating cash flow, Q2 FY2024, three months to 2023-09-30−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001140361-24-046312. Derived: 6-month figure less the 3-month figure.Report this figure(1,892)Operating cash flow, Q3 FY2024, three months to 2023-12-31−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-13, accession 0001140361-25-004153. Derived: 9-month figure less the 6-month figure.Report this figure(2,088)Operating cash flow, Q4 FY2024, three months to 2024-03-31−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-06-23, accession 0001140361-25-023259. Derived: 12-month figure less the 9-month figure.Report this figure(3,596)Operating cash flow, Q1 FY2025, three months to 2024-06-30−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure(4,239)Operating cash flow, Q2 FY2025, three months to 2024-09-30−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001140361-25-041804. Derived: 6-month figure less the 3-month figure.Report this figure(4,115)Operating cash flow, Q3 FY2025, three months to 2024-12-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-12, accession 0001140361-26-004924. Derived: 9-month figure less the 6-month figure.Report this figure(2,954)Operating cash flow, Q4 FY2025, three months to 2025-03-31−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure(1,801)Operating cash flow, Q1 FY2026, three months to 2025-06-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure(3,143)Operating cash flow, Q2 FY2026, three months to 2025-09-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001140361-25-041804. Derived: 6-month figure less the 3-month figure.Report this figure(2,230)Operating cash flow, Q3 FY2026, three months to 2025-12-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-12, accession 0001140361-26-004924. Derived: 9-month figure less the 6-month figure.Report this figure(1,695)Operating cash flow, Q4 FY2026, three months to 2026-03-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-18, accession 0001140361-26-025662. Derived: 12-month figure less the 9-month figure.Report this figure(3,221)Operating cash flow, Q1 FY2027, three months to 2026-06-30−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure
Capital expenditure$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)17.27m, Q1 FY2027
Line itemUnitQ2 FY20232022-09-30Q3 FY20232022-12-31Q1 FY20242023-06-30Q2 FY20242023-09-30Q3 FY20242023-12-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q1 FY20272026-06-30
Diluted shares (weighted)m shares7.4Diluted shares (weighted), Q2 FY2023, three months to 2022-09-307,425,166 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0000950170-23-062437.Report this figure7.4Diluted shares (weighted), Q3 FY2023, three months to 2022-12-317,435,472 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-12, accession 0000950170-24-013566.Report this figure7.4Diluted shares (weighted), Q1 FY2024, three months to 2023-06-307,435,533 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0000950170-24-094348.Report this figure7.6Diluted shares (weighted), Q2 FY2024, three months to 2023-09-307,552,677 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001140361-24-046312.Report this figure11.5Diluted shares (weighted), Q3 FY2024, three months to 2023-12-3111,506,257 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-13, accession 0001140361-25-004153.Report this figure10.9Diluted shares (weighted), Q1 FY2025, three months to 2024-06-3010,928,543 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001140361-25-030398.Report this figure11.5Diluted shares (weighted), Q2 FY2025, three months to 2024-09-3011,506,234 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure11.5Diluted shares (weighted), Q3 FY2025, three months to 2024-12-3111,506,234 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure15.9Diluted shares (weighted), Q1 FY2026, three months to 2025-06-3015,924,522 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure15.9Diluted shares (weighted), Q2 FY2026, three months to 2025-09-3015,924,522 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001140361-25-041804.Report this figure16.9Diluted shares (weighted), Q3 FY2026, three months to 2025-12-3116,933,620 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-12, accession 0001140361-26-004924.Report this figure17.3Diluted shares (weighted), Q1 FY2027, three months to 2026-06-3017,269,986 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure

Shares outstanding: 21.04mShares outstanding, period not labelled, at 2026-08-1121,035,930 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001140361-26-032632.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.